I absolutely agree with you. It is the 1st interim result time frame for NEU (Dec 2021) compared to DXB (March 2024) that one should look at.
Just a reminder:
Europe market represents USD $990mil potential market for DXB compared to global major markets of USD $6bil potential.
The deal with ADVANZ PHARMA is for Europe market plus CANADA, AUSTRALIA, NZ and is $230mil milestone payments, PLUS 15%-20% royalties.
What that means is the total milestone payments for all major markets combined is 5-6 times higher than the $230mil signed with Advanz Pharma.
$230mil × 5 = $1.15bil milestone payments potential.
PLUS, 15%-20% annual royalties on global sales.
Assuming DX-200 is a success and going to be approved by FDA, when global sales reaches USD $1bil out of total potential of USD $6bil, the 15%-20% royalties represents USD $150mil-$200mil annual income to DXB or around AUD $230mil-$300mil annual income.
If applying a biotech/medical stock standard PE of 15 to that income, it implies a $2.3bil-$3bil MC (just based on royalties income). Then add in another $1.15bil cash milestone payments, the MC can reach $3.3bil - $4.4bil potential.
Even taking a conservative approach to the potential at 50% discount, the MC potential is still $1.65bil - $2.2bil.
I think the market will wake up and value this stock more appropriately in the weeks and months ahead.
It is a compelling risk/reward stock for me.
- Forums
- ASX - By Stock
- DXB
- Ann: Dimerix Receives Initial Upfront Payment from Advanz Pharma
Ann: Dimerix Receives Initial Upfront Payment from Advanz Pharma, page-103
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
55.0¢ |
Change
-0.060(9.84%) |
Mkt cap ! $302.3M |
Open | High | Low | Value | Volume |
60.5¢ | 61.0¢ | 55.0¢ | $2.309M | 4.010M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 137019 | 55.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
55.5¢ | 22500 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 130691 | 0.550 |
4 | 35536 | 0.545 |
8 | 158059 | 0.540 |
3 | 46869 | 0.535 |
6 | 173766 | 0.530 |
Price($) | Vol. | No. |
---|---|---|
0.555 | 22500 | 1 |
0.560 | 21428 | 1 |
0.565 | 45284 | 3 |
0.575 | 10268 | 1 |
0.585 | 41022 | 3 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online